Cargando…

Editorial: Digital health and real-world evidence in onco-hematological patients

Detalles Bibliográficos
Autores principales:	Vener, Claudia, Lopez-Perez, Laura, Cabrera-Umpiérrez, Maria Fernanda, Fico, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682816/ https://www.ncbi.nlm.nih.gov/pubmed/38033498 http://dx.doi.org/10.3389/fonc.2023.1330407

Ejemplares similares

Editorial: Real-World evidence in onco-hematological patients
por: Vener, Claudia, et al.
Publicado: (2022)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Late Mortality, Subsequent Malignant Neoplasms and Hospitalisations in Long-Term Survivors of Adolescent and Young Adult Hematological Cancers
por: Trama, Annalisa, et al.
Publicado: (2022)

Takotsubo Syndrome (TTS) in Onco-Hematologic Patients: Retrospective Analysis and Focus on the Correlation or Not With Anticancer Drugs. Case Reports and Review of the Literature
por: Monti, Manlio, et al.
Publicado: (2022)

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
por: Bartolini, Claudia, et al.
Publicado: (2023)

Safety of switching between rituximab biosimilars in onco-hematology
por: Urru, Silvana A. M., et al.
Publicado: (2021)

Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
por: Vener, Claudia, et al.
Publicado: (2022)

Surgical Management of Rhinosinusitis in Onco-Hematological Patients
por: Di Girolamo, Stefano, et al.
Publicado: (2014)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Targeting immune-onco-metabolism for precision cancer therapy
por: Pajai, Sakshi, et al.
Publicado: (2023)

Health Related Quality of Life in Patients with Onco-hematological Diseases
por: La Nasa, Giorgio, et al.
Publicado: (2020)

Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
por: Marzano, Alfredo, et al.
Publicado: (2010)

Two cases of paralitic ileus in onco-hematologic patients
por: Carraro, Francesca, et al.
Publicado: (2012)

Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
por: Mangone, Lucia, et al.
Publicado: (2023)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Case reports in hematological malignancies: 2022
por: Antar, Ahmad, et al.
Publicado: (2023)

Onco-Esthetics Dilemma: Is There a Role for Electrocosmetic-Medical Devices?
por: Palmieri, Beniamino, et al.
Publicado: (2021)

Cardio-onco-hematology patients’ management in the context of the current COVID-19 pandemic
por: Lorca, Rebeca, et al.
Publicado: (2020)

Top-ten infections in onco-hematological patients (2015-2017)
por: Camps, Isabel Ruiz, et al.
Publicado: (2019)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Commentary: Onco-Esthetics Dilemma: Is There a Role for Electrocosmetic-Medical Devices?
por: Zdravkovic, Andrej, et al.
Publicado: (2021)

Editorial: COVID-19 and hematological malignancies: Volume II
por: Wilde, Lindsay, et al.
Publicado: (2022)

Editorial: The management of hematologic malignancies in lower-income countries
por: Ganesan, Prasanth, et al.
Publicado: (2023)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform
por: Efficace, Fabio, et al.
Publicado: (2022)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Virtual Reality Analgesia During Venipuncture in Pediatric Patients With Onco-Hematological Diseases
por: Atzori, Barbara, et al.
Publicado: (2018)

When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
por: Dai, Xiaofeng, et al.
Publicado: (2022)

Editorial: The Emerging Role for PP2A in Hematologic Malignancies
por: Ruvolo, Peter P.
Publicado: (2016)

Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
por: Lakomy, Radek, et al.
Publicado: (2020)

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
por: Crisci, Stefania, et al.
Publicado: (2019)

The profile of the onco-hematology patient in the palliative care: 4 years of experience
por: Couto, Maria Eduarda, et al.
Publicado: (2019)

Pediatric onco-hematological home care during COVID-19 pandemic
por: Amicucci, Matteo, et al.
Publicado: (2021)

Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care
por: Binder, Adam F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_818j08bnm7ho6ladia6tvspkgq